<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25698" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Interstitial Nephritis (Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Naik</surname>
            <given-names>Ruchi H.</given-names>
          </name>
          <aff>Vanderbilt University Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leslie</surname>
            <given-names>Stephen W.</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Annamaraju</surname>
            <given-names>Pavan</given-names>
          </name>
          <aff>Loma Linda University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ruchi Naik declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephen Leslie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pavan Annamaraju declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25698.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Interstitial nephritis, also called tubulointerstitial nephritis, includes a variety of mostly inflammatory kidney disorders that involve the renal tubules and interstitium but generally spare the glomeruli.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref>&#x000a0;</p>
        <p>The condition now known as acute interstitial nephritis (AIN), was first described in a renal biopsy specimen by&#x000a0;William Thomas Councilman, the chief pathologist of Brigham Hospital, in 1898.<xref ref-type="bibr" rid="article-25698.r2">[2]</xref>&#x000a0;In a post-mortem review of 42 cases, he described nonsuppurative interstitial lesions found predominantly in patients with streptococcal infections, which were later implicated in the immunopathogenesis of acute kidney injury (AKI).<xref ref-type="bibr" rid="article-25698.r2">[2]</xref></p>
        <p>Over the years, acute interstitial nephritis has been linked to a variety of infections, drugs, and systemic disorders.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r3">[3]</xref><xref ref-type="bibr" rid="article-25698.r4">[4]</xref>&#x000a0;Fortunately, it is generally reversible if diagnosed early and treated appropriately.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref>&#x000a0;</p>
        <p>Acute interstitial nephritis is the third leading cause of renal dysfunction in kidney transplants and it remains one of the most common causes of acute kidney injury (AKI) leading to renal failure.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref></p>
        <p>This review will not cover autosomal dominant tubulointerstitial kidney disease which is described elsewhere.<xref ref-type="bibr" rid="article-25698.r5">[5]</xref> See our companion StatPearls review article on "Autosomal Dominant Tubulointerstitial Kidney Disease."<xref ref-type="bibr" rid="article-25698.r5">[5]</xref></p>
      </sec>
      <sec id="article-25698.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Acute interstitial nephritis (also called acute tubulointerstitial nephritis) is associated with medications, infections, irradiation, hypokalemia, acute transplant rejection, and various systemic diseases.</p>
        <p>Drugs are the single most common cause of acute interstitial nephritis (AIN) in all age groups and account for up to 85% of cases.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r6">[6]</xref>&#x000a0;Antibiotics (penicillins, cephalosporins, ciprofloxacin, sulphonamides) and especially nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequently&#x000a0;associated with AIN. NSAIDs alone account for 44% of cases and antibiotics are responsible for 33%.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r7">[7]</xref> Proton pump inhibitors (PPIs), 5-aminosalicylates, lithium, rifampin, allopurinol, warfarin, chemotherapy agents, furosemide, thiazides, and acyclovir are other common drugs that can cause AIN.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r8">[8]</xref></p>
        <p>Acute interstitial nephritis is also recognized as the most common renal lesion in cases of acute kidney injury (AKI) cases including those associated with immune checkpoint inhibitors (e.g., pembrolizumab).<xref ref-type="bibr" rid="article-25698.r9">[9]</xref>&#x000a0;Immune checkpoint inhibitors are monoclonal antibodies used for cancer immunotherapy that are&#x000a0;proving to be an increasing cause of medication-induced interstitial nephritis.<xref ref-type="bibr" rid="article-25698.r10">[10]</xref>&#x000a0;As there are no alternative drugs for many of these cancer patients, the use of immune checkpoint inhibitors in those individuals who develop drug-induced interstitial nephritis poses a difficult medical and ethical challenge.<xref ref-type="bibr" rid="article-25698.r6">[6]</xref></p>
        <p>In theory, any drug can precipitate AIN, and the list of offending medications has been growing over time. There are over two hundred fifty drugs currently associated with drug-induced interstitial nephritis.<xref ref-type="bibr" rid="article-25698.r11">[11]</xref></p>
        <p>Infections can also cause acute interstitial nephritis, usually when associated with either obstruction or reflux. The following organisms have been associated with AIN:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacteria- <italic toggle="yes">E. coli</italic>, <italic toggle="yes">Campylobacter</italic>, <italic toggle="yes">Salmonella</italic>,&#x000a0;<italic toggle="yes">streptococci</italic></p>
          </list-item>
          <list-item>
            <p>Fungi - Histoplasmosis, coccidioidomycosis</p>
          </list-item>
          <list-item>
            <p>Parasites- Toxoplasmosis, leishmaniasis</p>
          </list-item>
          <list-item>
            <p>Spirochetes- Leptospirosis, syphilis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Viruses- Human immunodeficiency virus (HIV), cytomegalovirus, Epstein-Barr virus, measles, mumps, polyoma, hepatitis B, and herpes simplex virus</p>
          </list-item>
        </list>
        <p>Systemic disorders that have been found to cause acute and chronic AIN include sarcoidosis, Sjogren&#x02019;syndrome, IgG-4-related autoimmune disease, Goodpasture syndrome, and systemic lupus erythematosus (SLE), as well as tubulointerstitial nephritis and uveitis syndrome (TINU).<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r12">[12]</xref><xref ref-type="bibr" rid="article-25698.r13">[13]</xref><xref ref-type="bibr" rid="article-25698.r14">[14]</xref></p>
        <p>IgG-4-related autoimmune nephropathy is a rare disorder in which IgG and IgG-4 serum levels are elevated and multiple organs are affected.<xref ref-type="bibr" rid="article-25698.r15">[15]</xref><xref ref-type="bibr" rid="article-25698.r16">[16]</xref>&#x000a0;When the kidney is affected, it causes interstitial nephritis.<xref ref-type="bibr" rid="article-25698.r15">[15]</xref><xref ref-type="bibr" rid="article-25698.r16">[16]</xref><xref ref-type="bibr" rid="article-25698.r17">[17]</xref><xref ref-type="bibr" rid="article-25698.r18">[18]</xref>&#x000a0;IgG and IgG-4 serum levels are elevated and multiple organs are affected.<xref ref-type="bibr" rid="article-25698.r16">[16]</xref> It responds well to steroid therapy, but relapses are frequent when treatment is discontinued.<xref ref-type="bibr" rid="article-25698.r15">[15]</xref><xref ref-type="bibr" rid="article-25698.r16">[16]</xref><xref ref-type="bibr" rid="article-25698.r19">[19]</xref><xref ref-type="bibr" rid="article-25698.r20">[20]</xref></p>
        <p>Chronic interstitial nephritis has been associated with Alport syndrome, amyloidosis, atherosclerotic renal disease, chronic transplant nephropathy, cystinosis, drugs, heavy metal exposure (cadmium, lead, mercury), hypercalcemia, leukemia, medullary cystic disease, myeloma, nephrolithiasis, obstructive uropathy, oxalosis, and vesicoureteral reflux.</p>
        <p>Idiopathic<bold>&#x000a0;</bold>AIN is noted in certain unique disease entities, such as tubulointerstitial nephritis and uveitis syndrome, and anti-tubular basement membrane (anti-TBM) disease.<xref ref-type="bibr" rid="article-25698.r21">[21]</xref></p>
        <p><bold>Tubulointerstitial nephritis and uveitis syndrome</bold>&#x000a0;(TINU) is a rare disorder that presents with acute onset of granulomatous bilateral uveitis (redness, pain, and photophobia) and abnormal renal function from interstitial nephritis.<xref ref-type="bibr" rid="article-25698.r21">[21]</xref>&#x000a0;Renal involvement usually precedes the eye manifestations (65%) but they can occur concurrently (15%).</p>
        <p>Tubulointerstitial nephritis and uveitis syndrome is most common in children and younger adults aged &#x0003c;20 years, although cases are reported in older age groups greater than 60. Women are affected more than men, with no specific ethnic predominance. TINU is seen in 1%-2% of ophthalmology practices, but it represents up to a third of symptomatic acute bilateral uveitis cases in patients younger than 20 years.<xref ref-type="bibr" rid="article-25698.r21">[21]</xref></p>
        <p>The pathogenesis of TINU remains elusive. A combination of genetic susceptibility (Class II human leukocyte antigen subtypes), autoimmune, infectious, and iatrogenic factors are suspected of playing a role.<xref ref-type="bibr" rid="article-25698.r22">[22]</xref><xref ref-type="bibr" rid="article-25698.r23">[23]</xref>&#x000a0;It is associated with Epstein-Barr virus, leptospira, mycoplasma, and Yersinia infections.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r24">[24]</xref><xref ref-type="bibr" rid="article-25698.r25">[25]</xref></p>
        <p>A definitive diagnosis of TINU can be established by the combination of the presence of typical bilateral uveitis and interstitial nephritis on renal biopsy (histopathology) or by the presence of typical uveitis and meeting all three of the following clinical criteria:<xref ref-type="bibr" rid="article-25698.r26">[26]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Abnormal creatinine or reduced creatinine clearance</p>
          </list-item>
          <list-item>
            <p>Abnormal urinalysis (low-grade proteinuria, microscopic hematuria, sterile pyuria, white blood cell casts, eosinophiluria, elevated b2 microglobulin)</p>
          </list-item>
          <list-item>
            <p>Systemic illness for more than two weeks (fever, weight loss, fatigue, elevated erythrocyte sedimentation rate, anemia, and abnormal liver enzymes)</p>
          </list-item>
        </list>
        <p><bold>Anti-TBM disease</bold>&#x000a0;is a rare disorder that presents with acute kidney injury or chronic renal disease in all age groups.<xref ref-type="bibr" rid="article-25698.r27">[27]</xref> Polyuria and polydipsia are&#x000a0;the usual accompanying symptoms.<xref ref-type="bibr" rid="article-25698.r27">[27]</xref>&#x000a0;Microscopic hematuria and proteinuria (usually sub-nephrotic range) can be seen.<xref ref-type="bibr" rid="article-25698.r27">[27]</xref></p>
        <p>Anti-TBM antibodies are implicated in the pathogenesis of this disease. The anti-TBM antibodies are directed against the tubulointerstitial nephritis antigen, specifically in the kidney's proximal tubular basement membrane (TBM).<xref ref-type="bibr" rid="article-25698.r27">[27]</xref>&#x000a0;Tubulointerstitial nephritis antigen is a tubulogenesis regulatory protein.<xref ref-type="bibr" rid="article-25698.r27">[27]</xref></p>
        <p>Anti-TBM antibody formation can be triggered by drug exposure. The characteristic findings that clinch the diagnosis are the presence of anti-TBM antibodies in the serum, interstitial mononuclear infiltrate with tubulitis and variable eosinophils, acute tubular injury and interstitial edema on light microscopy, and strong linear IgG staining along the TBM with immunofluorescence.<xref ref-type="bibr" rid="article-25698.r27">[27]</xref><xref ref-type="bibr" rid="article-25698.r28">[28]</xref><xref ref-type="bibr" rid="article-25698.r29">[29]</xref>&#x000a0;Anti-TBM antibody titers are not commonly measured in clinical practice and it is unknown if such titers correlate to disease activity or severity.<xref ref-type="bibr" rid="article-25698.r28">[28]</xref> The glomeruli show only non-specific changes and electron microscopy does not demonstrate any immune complexes.<xref ref-type="bibr" rid="article-25698.r27">[27]</xref></p>
      </sec>
      <sec id="article-25698.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>A renal biopsy is required to definitively establish the diagnosis of acute interstitial nephritis. In real-world practice, not all suspected AIN cases are biopsied either due to improvement in the renal function after stopping the offending agent or because the condition is treated empirically. Therefore, the true incidence of AIN is likely underestimated.</p>
        <p>Acute interstitial nephritis is the most common cause of acute kidney injury.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref></p>
        <p>In the United States and worldwide, interstitial nephritis accounts for 10% to 15% of all renal diseases. It is even more prevalent in the Balkan countries.<xref ref-type="bibr" rid="article-25698.r30">[30]</xref></p>
        <p>According to large retrospective biopsy registries,&#x000a0;AIN was present in 1%&#x000a0;to 10% of all kidney biopsies, most of which were performed for suspected glomerulonephritis.</p>
        <p>Among the biopsies performed specifically for AKI evaluation, the incidence of AIN was higher, ranging from 6.5%&#x000a0;to 35% and 13.5% of all biopsies performed for acute kidney failure.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r4">[4]</xref><xref ref-type="bibr" rid="article-25698.r31">[31]</xref></p>
        <p>Drug-induced AIN represents more than two-thirds of all cases of AIN.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r4">[4]</xref><xref ref-type="bibr" rid="article-25698.r7">[7]</xref></p>
        <p>Worldwide, analgesic use is the most common cause of chronic interstitial nephritis.<xref ref-type="bibr" rid="article-25698.r32">[32]</xref></p>
        <p>Analgesic-related interstitial nephritis is five to six times more prevalent in women than men, most likely due to their higher usage of pain-relieving drugs. Women in their sixth and seventh decades of life are affected most often.</p>
        <p>Elderly patients (12%) are more vulnerable to drug-induced AIN as compared to younger individuals (3%).<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r4">[4]</xref><xref ref-type="bibr" rid="article-25698.r33">[33]</xref>&#x000a0;This is due to the increased use of antibiotics and NSAIDs in the older population as well as polypharmacy.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref></p>
        <p>Infections, systemic disorders, and idiopathic causes account for the majority of the other causes of AIN.</p>
      </sec>
      <sec id="article-25698.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The renal proximal tubules and interstitium are particularly susceptible to injury due to their high metabolic activity, increased exposure to concentrated drugs and toxins, and relatively limited blood supply.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r34">[34]</xref>&#x000a0;As inflammation and edema develop, the blood supply is diminished even more and the glomerular filtration rate (GFR) eventually begins to drop.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref>&#x000a0;Inflammatory cytokines (such as tissue necrosis factor alpha) accelerate this process and initiate the production of transforming growth factor-beta&#x000a0;from macrophages which results in fibrosis, tubular atrophy, and the permanent loss of kidney function seen in chronic interstitial nephritis.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref></p>
        <p>The immune mechanism mediates the pathogenesis of drug-induced AIN which is primarily an allergic reaction.<xref ref-type="bibr" rid="article-25698.r35">[35]</xref> Drugs act as haptens that bind to the cytoplasmic or extracellular components of renal tubular cells during secretion and generate a host immune response.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref> In some patients' serum, IgE levels are elevated, suggesting a type -1 hypersensitivity reaction.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r36">[36]</xref>&#x000a0;In other cases, the latent period between drug exposure and the development of a rash, eosinophilia, and the presence of positive drug skin tests suggests a T-cell-mediated type-IV hypersensitivity reaction.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r36">[36]</xref>&#x000a0;See our companion StatPearls reference article on "Allergic Interstitial Nephritis."<xref ref-type="bibr" rid="article-25698.r35">[35]</xref></p>
        <p>The exact pathophysiology of infection associated with AIN is still unclear, though some mechanisms are proposed. Some microbial antigens can deposit in the interstitium (planted antigen) that can mimic a normally present antigen in the tubular basement membrane, inducing an immune response directed against this antigen. Additionally, direct cytopathic effects of the microorganism or cytokine-mediated inflammation can also explain the damage.<xref ref-type="bibr" rid="article-25698.r33">[33]</xref><xref ref-type="bibr" rid="article-25698.r37">[37]</xref></p>
        <p>In chronic interstitial nephritis, damaged kidney cells activate nuclear transcription factors which release proinflammatory cytokines into the renal interstitium causing a prolonged inflammatory response.<xref ref-type="bibr" rid="article-25698.r38">[38]</xref> Increased transforming growth factor-beta&#x000a0;(TGF-&#x003b2;) directly stimulates basement membrane collagen production while inhibiting matrix-limiting enzymes (collagenases, metalloproteinases) resulting in fibrosis.<xref ref-type="bibr" rid="article-25698.r39">[39]</xref></p>
        <p>The pathogenesis of TINU is likely multifactorial. The ubiquitous findings of predominantly lymphocytic and monocytic interstitial infiltrate in the kidney biopsies and association with HLA-specific subtypes support the role of cellular immunity. More specifically, a delayed hypersensitivity type reaction mediated by the T-helper cell type TH1/TH17 axis is implicated in the pathogenesis of TINU syndrome.<xref ref-type="bibr" rid="article-25698.r4">[4]</xref><xref ref-type="bibr" rid="article-25698.r11">[11]</xref><xref ref-type="bibr" rid="article-25698.r23">[23]</xref><xref ref-type="bibr" rid="article-25698.r40">[40]</xref></p>
        <p>Anti-TBM antibodies are implicated in the pathogenesis of anti-TBM disease.<xref ref-type="bibr" rid="article-25698.r27">[27]</xref>&#x000a0;The anti-TBM antibodies are directed against the tubulointerstitial nephritis antigen, specifically in the kidney's proximal tubular basement membrane (TBM).<xref ref-type="bibr" rid="article-25698.r27">[27]</xref></p>
      </sec>
      <sec id="article-25698.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Interstitial edema and mononuclear cell infiltration, mostly T- lymphocytes into the tubules and interstitial space, are seen on light microscopy. Drug-induced AIN may involve eosinophils, although NSAIDs are unlikely to do this due to their anti-inflammatory effects.</p>
        <p>High numbers of neutrophils and plasma cells in the infiltrate are suggestive of a bacterial infectious etiology.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r36">[36]</xref><xref ref-type="bibr" rid="article-25698.r41">[41]</xref>&#x000a0;Additional features may include evidence of tubulitis with irregular tubular lumens, luminal dilation, apoptosis, tubular atrophy from inflammatory cell infiltration, and the loss of brush border membranes.<xref ref-type="bibr" rid="article-25698.r42">[42]</xref><xref ref-type="bibr" rid="article-25698.r43">[43]</xref></p>
        <p>Scattered plasma cells, macrophages, and occasionally noncaseating granulomas with eosinophils can also be found in the lesion. The granulomas may eventually become fibrotic.</p>
        <p>Interstitial fibrosis is often present. The extent of fibrosis is a key prognostic factor for renal recovery.</p>
        <p>When the AIN is associated with infection, the pathogen-specific molecular protein can be identified in the tissue samples.<xref ref-type="bibr" rid="article-25698.r40">[40]</xref><xref ref-type="bibr" rid="article-25698.r44">[44]</xref></p>
        <p>Immunofluorescence and electron microscopy are not generally very helpful in AIN as the findings are non-specific. Immunofluorescence shows a non-specific pattern consistent with autoimmune disease.<xref ref-type="bibr" rid="article-25698.r42">[42]</xref></p>
      </sec>
      <sec id="article-25698.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Acute interstitial nephritis typically presents initially with non-oliguric acute kidney injury, but oliguria can be present. The latent period between drug exposure and the onset of renal failure could be&#x000a0;several weeks to months (e.g., NSAIDs) if the patient were naive to the medication. In contrast, a second exposure to the drug can lead to renal manifestations within a matter of a few days.&#x000a0;In a case series of 121 patients with AIN, 40% developed renal failure requiring dialysis.<xref ref-type="bibr" rid="article-25698.r33">[33]</xref></p>
        <p>Patients may remain asymptomatic or have non-specific symptoms such as nausea, vomiting, malaise, myalgia, fatigue, weight loss, anorexia, headache, skin rashes, arthralgias, and flank pain.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref></p>
        <p>The other specific clinical features&#x000a0;may be related to the AIN's underlying etiology, such as sarcoidosis or SLE.</p>
        <p>Drug-induced AIN typically presents as an allergic-type reaction with a skin rash, low-grade fever, and eosinophilia, though all three manifestations are infrequently present simultaneously.&#x000a0;&#x000a0;</p>
        <p>Skin rashes may be present and are more commonly seen in drug-induced AIN from allopurinol, penicillins, phenytoin, and sulfonamides. The characteristics of such rashes are highly variable but have been described as erythroderma, maculopapular, morbilliform, and epidermal necrolysis.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref></p>
        <p>Hypertension is common in AIN due to sodium and fluid retention along with arterial vasoconstriction from increased angiotensin II activity secondary to tubulointerstitial inflammation.<xref ref-type="bibr" rid="article-25698.r31">[31]</xref><xref ref-type="bibr" rid="article-25698.r45">[45]</xref><xref ref-type="bibr" rid="article-25698.r46">[46]</xref><xref ref-type="bibr" rid="article-25698.r47">[47]</xref></p>
        <p>Flank pain tends to be associated with renal capsular distension from edema and inflammation in patients typically on rifampin.<xref ref-type="bibr" rid="article-25698.r42">[42]</xref></p>
        <p>The extrarenal manifestations of infection-associated AIN are mostly specific to infectious diseases. Similarly, AIN's clinical features associated with systemic disorders correlate with the spectrum of that particular condition (e.g., SLE, sarcoidosis, or Sjogren).</p>
        <p>Chronic interstitial nephritis is usually asymptomatic and is typically discovered incidentally on a routine laboratory examination.</p>
        <p>TINU is associated with bilateral uveitis and renal failure typically in young children and adolescents.<xref ref-type="bibr" rid="article-25698.r33">[33]</xref><xref ref-type="bibr" rid="article-25698.r42">[42]</xref><xref ref-type="bibr" rid="article-25698.r48">[48]</xref></p>
      </sec>
      <sec id="article-25698.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>When evaluating a patient with AKI, clinicians must pay attention to&#x000a0;the temporal relationship between the timing of the onset of AKI and exposure to a potential culprit drug. The classic triad of low-grade fever, skin rash, and eosinophilia is present in&#x000a0;only 10% of drug-induced AIN cases.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref></p>
        <p>The most common urinary findings include sterile pyuria (82%), microscopic hematuria, and proteinuria, usually subnephrotic (93%).<xref ref-type="bibr" rid="article-25698.r1">[1]</xref></p>
        <p>Proteinuria is usually present and significant but typically &#x0003c;1 gram/day except in drug-induced interstitial nephritis from NSAIDs, where it may reach the nephrotic syndrome range (3 grams protein/day or more).<xref ref-type="bibr" rid="article-25698.r1">[1]</xref> This is even more likely if there is a concomitant renal disorder such as minimal change disease or membranous nephropathy.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref>&#x000a0;Proteinuria is more likely in older patients.<xref ref-type="bibr" rid="article-25698.r49">[49]</xref></p>
        <p>White blood cell (WBC), hyaline, and granular casts can be present on urinary sediment examination.</p>
        <p>Microscopic hematuria is reported in 67% of cases. Peripheral eosinophilia is seen in approximately 35% of drug-induced AIN cases and is less common with NSAIDs. The positive predictive value of eosinophiluria is 38%.<xref ref-type="bibr" rid="article-25698.r50">[50]</xref></p>
        <p>Urinary eosinophils, once considered a reliable diagnostic marker for acute interstitial nephritis, have been proven to lack sensitivity and specificity, making it an unreliable test for AIN although it may be somewhat suggestive if found.</p>
        <p><bold>Laboratory studies</bold> typically show:&#x000a0;<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r40">[40]</xref><xref ref-type="bibr" rid="article-25698.r42">[42]</xref><xref ref-type="bibr" rid="article-25698.r50">[50]</xref><xref ref-type="bibr" rid="article-25698.r51">[51]</xref><xref ref-type="bibr" rid="article-25698.r52">[52]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Unexplained increase in serum creatinine.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>A BUN/creatinine ratio &#x02264;12 suggests AIN.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hyperkalemic, hyperchloremic metabolic acidosis that appears excessive for the level of azotemia. (High serum chloride and potassium, low bicarbonate.)</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Eosinophilia and/or increased urinary eosinophils may be present (most often associated with methicillin use.) Eosinophilia is found in about 50% of AIN cases but generally not in those associated with NSAID use.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Anemia may be present due to the development of erythropoietin resistance and diminished production.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Elevated erythrocyte sedimentation rate (ESR) and/or high C-reactive protein.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Elevated serum IgE levels. Usually associated with drug-induced allergic AIN.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Proteinuria (usually significant but &#x0003c;1 gram/day), pyuria, or hematuria on urinalysis may be present. Nephrotic syndrome (3 grams or more of urinary protein/day) is rare but may be associated with NSAID use.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>WBC casts in the urine without evidence of pyelonephritis. Red cell casts would be rare.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hyaline and granular casts on urinalysis are likely.</p>
          </list-item>
        </list>
        <p>Renal imaging, such as ultrasound or CT scans, may show an increase in renal dimensions or increased cortical hyperechogenicity but are primarily used to exclude obstructive uropathy if no hydronephrosis is found.<xref ref-type="bibr" rid="article-25698.r40">[40]</xref><xref ref-type="bibr" rid="article-25698.r42">[42]</xref><xref ref-type="bibr" rid="article-25698.r50">[50]</xref></p>
        <p>Gallium renal scans tend to be positive, indicating interstitial inflammation, but sensitivity and specificity are relatively low at only 50% to 60%, and they will also tend to be positive in glomerulonephritis and pyelonephritis.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r53">[53]</xref><xref ref-type="bibr" rid="article-25698.r54">[54]</xref>&#x000a0;Gallium scans are most useful when a renal biopsy cannot be performed as confirmation of suspected AIN cases.<xref ref-type="bibr" rid="article-25698.r43">[43]</xref></p>
        <p>The non-specific nature of the symptoms often causes a delay in the diagnosis as the presentation may be similar to glomerulonephritis and acute tubular necrosis.</p>
        <p>Interstitial nephritis from lead nephropathy can be diagnosed with an EDTA lead mobilization test or radiographic fluorescence testing of lead content in bone. The EDTA lead mobilization test is done by injecting IV or IM two grams of calcium disodium versenate, a chelating agent, and then immediately measuring a 24-hour urine sample for lead. More than 600 mg of lead in the sample is considered abnormal. If lead exposure is found, then long-term chelation therapy is recommended.</p>
        <p>Several urinary biomarkers have been proposed to help diagnose and monitor AIN. These include monocyte chemotactic peptide-1, alpha1-microglobulin, and &#x003b2;2-microglobulin.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r36">[36]</xref></p>
        <p>The combination of elevated serum creatinine and high urinary &#x003b2;2-microglobulin was found to have a 100% positive predictive value for detecting patients likely to have TINU.<xref ref-type="bibr" rid="article-25698.r55">[55]</xref></p>
        <p>Urinary CXCL9 has been found to be a potentially very useful clinical diagnostic biomarker for acute interstitial nephritis.<xref ref-type="bibr" rid="article-25698.r56">[56]</xref><xref ref-type="bibr" rid="article-25698.r57">[57]</xref>&#x000a0;CXCL9 is a chemokine that promotes interstitial nephritis and is associated with lymphocyte chemotaxis.<xref ref-type="bibr" rid="article-25698.r56">[56]</xref><xref ref-type="bibr" rid="article-25698.r57">[57]</xref>&#x000a0;Using sandwich immunoassay techniques, urinary levels of CXCL9 were found to be 7.6 times higher in patients with AIN than in controls.<xref ref-type="bibr" rid="article-25698.r56">[56]</xref></p>
        <p>A renal biopsy is required for a definitive diagnosis.<xref ref-type="bibr" rid="article-25698.r33">[33]</xref><xref ref-type="bibr" rid="article-25698.r42">[42]</xref><xref ref-type="bibr" rid="article-25698.r48">[48]</xref><xref ref-type="bibr" rid="article-25698.r50">[50]</xref><xref ref-type="bibr" rid="article-25698.r58">[58]</xref></p>
        <p>
<bold>Indications for a Renal Biopsy:&#x000a0;</bold>
<xref ref-type="bibr" rid="article-25698.r50">[50]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute renal failure and AIN is suspected clinically</p>
          </list-item>
          <list-item>
            <p>Possible triggering medication exposure</p>
          </list-item>
          <list-item>
            <p>Symptoms include rash, fever, arthralgias</p>
          </list-item>
          <list-item>
            <p>Laboratory data suggestive of AIN (see laboratory studies above)</p>
          </list-item>
          <list-item>
            <p>Failure to improve after withdrawal of all possible medication triggers</p>
          </list-item>
        </list>
        <p>
<bold>Contraindications for a Renal Biopsy:&#x000a0;</bold>
<xref ref-type="bibr" rid="article-25698.r50">[50]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Uncorrected bleeding disorder</p>
          </list-item>
          <list-item>
            <p>Solitary kidney (relative contraindication)</p>
          </list-item>
          <list-item>
            <p>Patient unable to cooperate with the procedure</p>
          </list-item>
          <list-item>
            <p>End-stage renal disease with small, atrophic kidneys</p>
          </list-item>
          <list-item>
            <p>Severe uncontrolled hypertension</p>
          </list-item>
          <list-item>
            <p>Sepsis, pyelonephritis, or active UTI</p>
          </list-item>
          <list-item>
            <p>Patient refusal</p>
          </list-item>
        </list>
        <p>&#x000a0;<bold>Summary of Common Clinical Features and Laboratory Findings Suggesting Interstitial Nephritis Would Include:</bold></p>
        <list list-type="bullet">
          <list-item>
            <p>Acute renal failure</p>
          </list-item>
          <list-item>
            <p>Administration of a new medication coinciding with the onset of other symptoms</p>
          </list-item>
          <list-item>
            <p>Anemia</p>
          </list-item>
          <list-item>
            <p>Arthralgias</p>
          </list-item>
          <list-item>
            <p>Elevated ESR or C-reactive protein</p>
          </list-item>
          <list-item>
            <p>Eosinophilia and/or eosinophiluria</p>
          </list-item>
          <list-item>
            <p>Fever</p>
          </list-item>
          <list-item>
            <p>Hematuria (usually microscopic)</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
          <list-item>
            <p>Hyperkalemic, hyperchloremic metabolic acidosis.</p>
          </list-item>
          <list-item>
            <p>Negative renal ultrasound findings for hydronephrosis</p>
          </list-item>
          <list-item>
            <p>NSAID use</p>
          </list-item>
          <list-item>
            <p>Proteinuria (usually &#x0003c;1 gram per day)</p>
          </list-item>
          <list-item>
            <p>Pyuria without fever or infection (sterile)</p>
          </list-item>
          <list-item>
            <p>Skin rash&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Urinary casts (WBC, hyaline, and granular but not RBC)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25698.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment should be based on the underlying etiology whenever possible.<xref ref-type="bibr" rid="article-25698.r36">[36]</xref></p>
        <p>The mainstay of treatment of drug-induced AIN is the timely identification and discontinuation of the offending drug.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r6">[6]</xref><xref ref-type="bibr" rid="article-25698.r35">[35]</xref>&#x000a0;A renal biopsy should be promptly performed to establish a definitive diagnosis, especially if there is no improvement after drug discontinuation within three to seven days.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r35">[35]</xref></p>
        <p>The possibility of the absence of AIN on biopsy may impact the patient's medication regimen. The extent of interstitial fibrosis and any significant delay in starting corticosteroid therapy are risk factors&#x000a0;linked to increased residual renal damage.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref>&#x000a0;If renal failure is severe, supportive therapy with dialysis may be required.&#x000a0;&#x000a0;</p>
        <p>There is&#x000a0;a paucity of data from randomized controlled trials to guide the treatment for AIN. Observational studies have shown improved renal recovery with early initiation of corticosteroids, which suppress T cell-mediated inflammation and may plausibly mitigate the development of fibrosis and residual renal damage.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r59">[59]</xref></p>
        <p>A systematic review of the benefit of corticosteroids in drug-induced interstitial nephritis demonstrated conflicting results, with half of the studies showing no improvement with steroids while the other half showed a benefit.<xref ref-type="bibr" rid="article-25698.r60">[60]</xref></p>
        <p>In the absence of definitive studies or authoritative evidence, most experts will use steroids in these cases, especially if there is no obvious improvement within three to seven days after the withdrawal of the triggering medication.<xref ref-type="bibr" rid="article-25698.r35">[35]</xref></p>
        <p>The available prospective studies with a limited study population have shown no differences in the efficacy of oral versus intravenous pulse doses of steroids to treat AIN. One of the potential regimens of steroid therapy can be administering intravenous methylprednisolone 500 to 1,000 mg for three days, followed by oral prednisone 1mg/kg for two weeks with a subsequent tapering over 4&#x000a0;to 6 weeks.<xref ref-type="bibr" rid="article-25698.r61">[61]</xref></p>
        <p>Evidence of renal recovery is expected to be seen after two weeks of steroid therapy. In a study of 182 patients with biopsy-proven AIN, high-dose steroid use for more than three weeks and steroid tapering over five weeks did not significantly benefit renal function recovery.</p>
        <p>Corticosteroids have been used for the treatment of AIN associated with sarcoidosis, TINU, and anti-TBM antibody-mediated disease with variable results.<xref ref-type="bibr" rid="article-25698.r4">[4]</xref><xref ref-type="bibr" rid="article-25698.r11">[11]</xref><xref ref-type="bibr" rid="article-25698.r33">[33]</xref><xref ref-type="bibr" rid="article-25698.r37">[37]</xref><xref ref-type="bibr" rid="article-25698.r40">[40]</xref><xref ref-type="bibr" rid="article-25698.r42">[42]</xref><xref ref-type="bibr" rid="article-25698.r51">[51]</xref><xref ref-type="bibr" rid="article-25698.r62">[62]</xref><xref ref-type="bibr" rid="article-25698.r63">[63]</xref>&#x000a0;The addition of immunosuppressants (azathioprine, cyclosporine) to corticosteroids appears to be beneficial in this group.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref><xref ref-type="bibr" rid="article-25698.r61">[61]</xref><xref ref-type="bibr" rid="article-25698.r64">[64]</xref>&#x000a0;Steroids do not play a major role in the treatment of infection-related AIN, where antibiotic therapy of the underlying infectious agent is required.<xref ref-type="bibr" rid="article-25698.r61">[61]</xref></p>
        <p>Mycophenolate mofetil at 1 or 2 grams daily appears to be helpful in steroid-resistant situations or when steroids are contraindicated.<xref ref-type="bibr" rid="article-25698.r12">[12]</xref><xref ref-type="bibr" rid="article-25698.r65">[65]</xref><xref ref-type="bibr" rid="article-25698.r66">[66]</xref><xref ref-type="bibr" rid="article-25698.r67">[67]</xref>&#x000a0;It acts as an immunosuppressive agent that is being successfully used for a number of autoimmune disorders, such as ANCA-associated vasculitis, IgA nephropathy, and lupus nephritis, as well as interstitial nephritis.<xref ref-type="bibr" rid="article-25698.r68">[68]</xref></p>
        <p><bold>TINU </bold>has no&#x000a0;published therapeutic guidelines or recognized consensus treatment protocols.<xref ref-type="bibr" rid="article-25698.r21">[21]</xref>&#x000a0;Therapy generally consists of&#x000a0;steroids, but immunosuppressants such as azathioprine have been used in cases where corticosteroids have failed or cannot be used.<xref ref-type="bibr" rid="article-25698.r21">[21]</xref>&#x000a0;Mycophenolate mofetil has also been used.<xref ref-type="bibr" rid="article-25698.r69">[69]</xref> The uveitis is treated with cycloplegics. The overall positive response is about 50%.<xref ref-type="bibr" rid="article-25698.r26">[26]</xref><xref ref-type="bibr" rid="article-25698.r70">[70]</xref><xref ref-type="bibr" rid="article-25698.r71">[71]</xref>&#x000a0;Most patients with TINU recover reasonable renal function as the nephropathy is thought to be self-limiting.<xref ref-type="bibr" rid="article-25698.r66">[66]</xref></p>
        <p><bold>Anti-TBM disease&#x000a0;</bold>is exceedingly rare, and the optimal therapy is unknown.<xref ref-type="bibr" rid="article-25698.r28">[28]</xref> There are anecdotal reports and case studies suggesting corticosteroid therapy, along with the elimination of any underlying triggers, may be helpful.<xref ref-type="bibr" rid="article-25698.r28">[28]</xref> It is also unknown if a therapeutic plasma exchange, which would remove anti-TBM antibodies, is beneficial.<xref ref-type="bibr" rid="article-25698.r28">[28]</xref><xref ref-type="bibr" rid="article-25698.r29">[29]</xref></p>
      </sec>
      <sec id="article-25698.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>All other causes of AKI can be considered in the differential diagnosis of AIN.</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute tubular necrosis (ATN) can be seen in the context of drug toxicity (e.g., vancomycin) and is associated with granular or muddy brown casts in the urine sediment</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Atheroembolic disease can present with a rash (livedo reticularis), digital infarcts, and peripheral eosinophilia. More common in older patients, obese individuals, and those with a history of endovascular disease.<xref ref-type="bibr" rid="article-25698.r72">[72]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Dysmorphic red blood cells (RBCs), red blood cell casts, and nephrotic range proteinuria are seen in glomerular diseases.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Glomerulonephritis can present similarly to AIN, but can be differentiated by the presence of red blood cell casts on microscopic urinalysis as well as light and electron microscopy of the glomeruli from a renal biopsy.<xref ref-type="bibr" rid="article-25698.r73">[73]</xref><xref ref-type="bibr" rid="article-25698.r74">[74]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Post-renal AKI can be identified by renal imaging. Symptoms are likely to include oliguria and/or flank pain.<xref ref-type="bibr" rid="article-25698.r75">[75]</xref><xref ref-type="bibr" rid="article-25698.r76">[76]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pre-renal AKI is associated with a history and exam findings consistent with volume depletion and clinically responds well to a fluid challenge.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Vasculitis can present with AKI and a rash. The vasculitic rash is usually purpuric, while in drug-induced AIN, a maculopapular rash consistent with an allergic pattern is usually noted.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25698.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Initial studies of methicillin-associated and other drug-associated AIN showed a relatively favorable recovery of renal function in the majority of patients.<xref ref-type="bibr" rid="article-25698.r41">[41]</xref> However, recent reports of drug-induced AIN show higher residual renal damage rates in 40%&#x000a0;to 50% of cases. NSAID-associated AIN portends a poorer prognosis as it is usually not identified early. Granulomatous interstitial nephritis and chronic interstitial nephritis generally have a poorer prognosis.<xref ref-type="bibr" rid="article-25698.r61">[61]</xref></p>
        <p>The prognosis of AIN associated with other etiologies has not been fully understood. The factors associated with incomplete renal recovery are any significant delay in the initiation of corticosteroid therapy, the duration of AKI, NSAID-associated AIN, as well as the degree of interstitial fibrosis and tubular atrophy seen on a renal biopsy.<xref ref-type="bibr" rid="article-25698.r4">[4]</xref><xref ref-type="bibr" rid="article-25698.r33">[33]</xref><xref ref-type="bibr" rid="article-25698.r37">[37]</xref></p>
        <p>In general, patients who stop taking the AIN-associated drug within two weeks of the start of symptoms are more likely to return to their baseline renal function than those who wait three weeks or longer.<xref ref-type="bibr" rid="article-25698.r50">[50]</xref></p>
        <p>Chronic interstitial nephritis often demonstrates interstitial scarring, fibrosis, tubular atrophy, and late glomerular involvement which frequently results in slowly progressive renal disease and eventually end-stage kidney failure.<xref ref-type="bibr" rid="article-25698.r39">[39]</xref><xref ref-type="bibr" rid="article-25698.r77">[77]</xref></p>
      </sec>
      <sec id="article-25698.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Older patients are more prone to complications as well as those who suffer a delay in starting treatment.</p>
        <p>Some degree of residual renal failure is a common complication. This may progress to end-stage kidney failure.</p>
        <p>More severe or prolonged cases can progress to extensive fibrosis, tubular atrophy, glomerulopathy, acid-base abnormalities, and renal failure.</p>
        <p>TINU may progress to Fanconi syndrome.<xref ref-type="bibr" rid="article-25698.r78">[78]</xref><xref ref-type="bibr" rid="article-25698.r79">[79]</xref><xref ref-type="bibr" rid="article-25698.r80">[80]</xref></p>
        <p>Patients with AIN from antineutrophil cytoplasmic antibody-associated vasculitis will progress to necrotizing crescentic glomerulonephritis if steroid therapy is not started promptly.<xref ref-type="bibr" rid="article-25698.r81">[81]</xref><xref ref-type="bibr" rid="article-25698.r82">[82]</xref></p>
        <p>Anemia can result from reduced production and/or unresponsiveness to erythropoietin.<xref ref-type="bibr" rid="article-25698.r43">[43]</xref></p>
        <p>AIN associated with prolonged NSAID use can progress to nephrotic syndrome.<xref ref-type="bibr" rid="article-25698.r1">[1]</xref></p>
        <p>Acute interstitial nephritis increases angiotensin II activity which results in hypertension from arterial vasoconstriction as well as sodium and fluid retention.<xref ref-type="bibr" rid="article-25698.r45">[45]</xref><xref ref-type="bibr" rid="article-25698.r46">[46]</xref><xref ref-type="bibr" rid="article-25698.r47">[47]</xref></p>
      </sec>
      <sec id="article-25698.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Antibiotics, NSAIDs, and proton pump inhibitors are commonly prescribed and over-the-counter medications that can precipitate&#x000a0;AIN. While patients may or may not develop noticeable clinical symptoms of AIN, it can still result in an irreversible loss of kidney function. Therefore, patient education regarding the possible adverse&#x000a0;effects of these drugs is paramount.</p>
        <p>Patients must be advised to limit the use of these medications except when clearly indicated under the treating clinician's close supervision. If a patient develops any clinical symptoms, such as nausea, vomiting, hematuria, arthralgia, or a rash, they should seek immediate medical attention.</p>
        <p>Patients should also be cautioned not to exceed the recommended dosages for these medications.</p>
      </sec>
      <sec id="article-25698.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Acute interstitial nephritis should be considered in any patient presenting with an acute kidney injury and new onset of unexplained renal failure.</p>
        <p>New azotemia with nephrotic syndrome in a patient taking NSAIDs is likely to be drug-induced interstitial nephritis.</p>
        <p>A BUN/creatinine ratio &#x02264;12 is suggestive of acute interstitial nephritis in patients with acute kidney injury.<xref ref-type="bibr" rid="article-25698.r52">[52]</xref></p>
        <p>Consider using mycophenolate mofetil if steroids are ineffective or cannot be used to treat interstitial nephritis.</p>
        <p>A renal biopsy can help diagnose interstitial nephritis but not the underlying cause.&#x000a0;If the underlying etiology of the interstitial nephritis is unclear and not thought to be allergic or drug-induced, consider the following to identify the cause:</p>
        <list list-type="bullet">
          <list-item>
            <p>Antineutrophilic cytoplasmic antibodies (ANCA) to rule out ANCA-related vasculitis disorders.</p>
          </list-item>
          <list-item>
            <p>Antinuclear, anti-smith, and anti-double-stranded DNA antibodies to screen for systemic lupus erythematosus (SLE).</p>
          </list-item>
          <list-item>
            <p>Chest X-ray or CT to screen for tuberculosis and sarcoidosis.</p>
          </list-item>
          <list-item>
            <p>PPD tuberculosis skin test or a serum interferon-gamma release assay.</p>
          </list-item>
          <list-item>
            <p>Rapid plasma reagin&#x000a0;(RPR) test for syphilis.</p>
          </list-item>
          <list-item>
            <p>Renal ultrasound to identify hydronephrosis. (Adding a KUB helps identify nephrolithiasis.)</p>
          </list-item>
          <list-item>
            <p>Serologic testing for coccidioidomycosis, Epstein-Barr virus, histoplasmosis, HIV, and toxoplasmosis.</p>
          </list-item>
          <list-item>
            <p>Serum angiotensin-converting enzyme, calcium, and 24-hour urinary calcium as screening tests for sarcoidosis.</p>
          </list-item>
          <list-item>
            <p>Serum C3 and C4 to evaluate for SLE and IgG4.</p>
          </list-item>
          <list-item>
            <p>Serum protein electrophoresis.</p>
          </list-item>
          <list-item>
            <p>Serum rheumatoid factor, antinuclear antibodies, and C-reactive protein to screen for Sjogren syndrome. A lip biopsy would be definitive.</p>
          </list-item>
          <list-item>
            <p>Slit lamp examination for patients with ocular pain, erythema, or discomfort for possible TINU.</p>
          </list-item>
          <list-item>
            <p>Urinary antigen for legionella.</p>
          </list-item>
          <list-item>
            <p>Urine culture for leptospirosis.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25698.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Drug-induced acute interstitial nephritis is the most common form of AIN. Many over-the-counter and common prescription medications can cause this disorder.</p>
        <p>Clinicians play a crucial role in recommending and selecting&#x000a0;medications based on patients' conditions&#x000a0;and monitoring for adverse reactions.</p>
        <p>A nephrologist should be consulted to evaluate the cause of any newly discovered renal failure, provide recommendations on medication management, advise on a renal biopsy, and prepare a customized treatment plan.</p>
        <p>The pathologist can confirm the presence of AIN on a renal biopsy specimen. Pharmacists and nurses are vital to educating patients&#x000a0;about the possible adverse effects of medications.&#x000a0;</p>
        <p>In severe cases of AIN, the patient may need to be hospitalized.</p>
        <p>Interprofessional care coordination by clinicians, nurses, pharmacists, dermatologists, ophthalmologists, infectious disease specialists, nephrologists, and other health professionals is vital to enhancing care, improving patient safety, and optimizing outcomes.</p>
      </sec>
      <sec id="article-25698.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25698&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25698">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25698/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25698">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25698.s16">
        <title>References</title>
        <ref id="article-25698.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bhandari</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thada</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Rout</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Arif</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <chapter-title>Tubulointerstitial Nephritis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>1</month>
            <day>19</day>
            <pub-id pub-id-type="pmid">32491469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eknoyan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Interstitial Nephritis: Wherefrom, Wherein, and Whereto.</article-title>
            <source>Exp Clin Transplant</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>Suppl 2</issue>
            <fpage>42</fpage>
            <page-range>42-45</page-range>
            <pub-id pub-id-type="pmid">37496342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eknoyan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The early modern kidney--nephrology in and about the nineteenth century. Part 1.</article-title>
            <source>Semin Dial</source>
            <year>2013</year>
            <season>Jan-Feb</season>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-84</page-range>
            <pub-id pub-id-type="pmid">23278189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raghavan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Eknoyan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Acute interstitial nephritis - a reappraisal and update.</article-title>
            <source>Clin Nephrol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>82</volume>
            <issue>3</issue>
            <fpage>149</fpage>
            <page-range>149-62</page-range>
            <pub-id pub-id-type="pmid">25079860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r5">
          <label>5</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Shamam</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Hashmi</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <chapter-title>Autosomal Dominant Tubulointerstitial Kidney Disease</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">33760469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanchez-Alamo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cases-Corona</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fernandez-Juarez</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Facing the Challenge of Drug-Induced Acute Interstitial Nephritis.</article-title>
            <source>Nephron</source>
            <year>2023</year>
            <volume>147</volume>
            <issue>2</issue>
            <fpage>78</fpage>
            <page-range>78-90</page-range>
            <pub-id pub-id-type="pmid">35830831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clarkson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Giblin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>O'Kelly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Walshe</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Conlon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>O'Meara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dormon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Donohoe</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acute interstitial nephritis: clinical features and response to corticosteroid therapy.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>2778</fpage>
            <page-range>2778-83</page-range>
            <pub-id pub-id-type="pmid">15340098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez-Valenzuela</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Draibe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fulladosa</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Gom&#x000e0;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ant&#x000f3;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cruzado</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Torras</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acute Tubulointerstitial Nephritis in Clinical Oncology: A Comprehensive Review.</article-title>
            <source>Int J Mol Sci</source>
            <year>2021</year>
            <month>Feb</month>
            <day>26</day>
            <volume>22</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">33652638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wanchoo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Karam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uppal</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Barta</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Deray</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Devoe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Launay-Vacher</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Jhaveri</surname>
                <given-names>KD</given-names>
              </name>
              <collab>Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors</collab>
            </person-group>
            <article-title>Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review.</article-title>
            <source>Am J Nephrol</source>
            <year>2017</year>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>160</fpage>
            <page-range>160-169</page-range>
            <pub-id pub-id-type="pmid">28076863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barreto</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Rule</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Management of Drug-Associated Acute Interstitial Nephritis.</article-title>
            <source>Kidney360</source>
            <year>2020</year>
            <month>Jan</month>
            <day>30</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-64</page-range>
            <pub-id pub-id-type="pmid">35372864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raghavan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shawar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of Drug-Induced Interstitial Nephritis.</article-title>
            <source>Adv Chronic Kidney Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>64</fpage>
            <page-range>64-71</page-range>
            <pub-id pub-id-type="pmid">28284381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cornell</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <article-title>IgG4-Related Tubulointerstitial Nephritis.</article-title>
            <source>Adv Chronic Kidney Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>94</fpage>
            <page-range>94-100</page-range>
            <pub-id pub-id-type="pmid">28284385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maripuri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grande</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Osborn</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Fervenza</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Matteson</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Donadio</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Hogan</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Renal involvement in primary Sj&#x000f6;gren's syndrome: a clinicopathologic study.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>9</issue>
            <fpage>1423</fpage>
            <page-range>1423-31</page-range>
            <pub-id pub-id-type="pmid">19679669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Srinivas</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Emmanuel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Parameshwaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Negi</surname>
                <given-names>VS</given-names>
              </name>
            </person-group>
            <article-title>Renal involvement in primary Sjogren's syndrome: a prospective cohort study.</article-title>
            <source>Rheumatol Int</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>38</volume>
            <issue>12</issue>
            <fpage>2251</fpage>
            <page-range>2251-2262</page-range>
            <pub-id pub-id-type="pmid">30155666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peyronel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vaglio</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>IgG4-Related Kidney Disease.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2023</year>
            <month>Aug</month>
            <day>01</day>
            <volume>18</volume>
            <issue>8</issue>
            <fpage>994</fpage>
            <page-range>994-996</page-range>
            <pub-id pub-id-type="pmid">37418275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r16">
          <label>16</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Nambiar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oliver</surname>
                <given-names>TI</given-names>
              </name>
            </person-group>
            <chapter-title>IgG4-Related Disease</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">29763000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvadori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsalouchos</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Immunoglobulin G4-related kidney diseases: An updated review.</article-title>
            <source>World J Nephrol</source>
            <year>2018</year>
            <month>Jan</month>
            <day>06</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-40</page-range>
            <pub-id pub-id-type="pmid">29359118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mbengue</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goumri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Niang</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>IgG4-related kidney disease: Pathogenesis, diagnosis, and treatment.</article-title>
            <source>Clin Nephrol</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>95</volume>
            <issue>6</issue>
            <fpage>292</fpage>
            <page-range>292-302</page-range>
            <pub-id pub-id-type="pmid">33860756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saeki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Imai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamazaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Origuchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hirabayashi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Homma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tsubata</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fukase</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ishioka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Miyazaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Masaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Umehara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sugai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Narita</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis.</article-title>
            <source>Kidney Int</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>78</volume>
            <issue>10</issue>
            <fpage>1016</fpage>
            <page-range>1016-23</page-range>
            <pub-id pub-id-type="pmid">20720530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Inoue</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yoneda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ozaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsubara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nagai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Okumura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Toshima</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Toyama</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Minami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gabata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zen</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>IgG4-related disease: dataset of 235 consecutive patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>94</volume>
            <issue>15</issue>
            <fpage>e680</fpage>
            <pub-id pub-id-type="pmid">25881845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Southgate</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Harmer</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Renal outcomes in tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review and meta-analysis.</article-title>
            <source>J Nephrol</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>507</fpage>
            <page-range>507-519</page-range>
            <pub-id pub-id-type="pmid">36396848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pakzad-Vaezi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pepple</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Tubulointerstitial nephritis and uveitis.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>629</fpage>
            <page-range>629-635</page-range>
            <pub-id pub-id-type="pmid">28806188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clive</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Vanguri</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>The Syndrome of Tubulointerstitial Nephritis With Uveitis (TINU).</article-title>
            <source>Am J Kidney Dis</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>72</volume>
            <issue>1</issue>
            <fpage>118</fpage>
            <page-range>118-128</page-range>
            <pub-id pub-id-type="pmid">29429748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdulkader</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>MV</given-names>
              </name>
            </person-group>
            <article-title>The kidney in leptospirosis.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>12</issue>
            <fpage>2111</fpage>
            <page-range>2111-20</page-range>
            <pub-id pub-id-type="pmid">18446381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hiraoka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hori</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsukahara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sudo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ultrasonographic findings of acute tubulointerstitial nephritis.</article-title>
            <source>Am J Nephrol</source>
            <year>1996</year>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>154</fpage>
            <page-range>154-8</page-range>
            <pub-id pub-id-type="pmid">8919233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mandeville</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Levinson</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>The tubulointerstitial nephritis and uveitis syndrome.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2001</year>
            <season>Nov-Dec</season>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>195</fpage>
            <page-range>195-208</page-range>
            <pub-id pub-id-type="pmid">11738428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lusco</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Fogo</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Najafian</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alpers</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>AJKD Atlas of Renal Pathology: Anti-Tubular Basement Membrane Antibody Disease.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>70</volume>
            <issue>1</issue>
            <fpage>e3</fpage>
            <page-range>e3-e4</page-range>
            <pub-id pub-id-type="pmid">28646985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rifai</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Denig</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Caza</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Rifai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dahan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alamin</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Antitubular Basement Membrane Antibody Disease Associated with Nivolumab Infusion and Concomitant Acute Pyelonephritis Leading to Acute Kidney Injury&#x02009;:&#x02009;a Case Report and Literature Review.</article-title>
            <source>Case Rep Nephrol</source>
            <year>2023</year>
            <volume>2023</volume>
            <fpage>6681756</fpage>
            <pub-id pub-id-type="pmid">37051373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McAdoo</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Pusey</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Anti-Glomerular Basement Membrane Disease.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2017</year>
            <month>Jul</month>
            <day>07</day>
            <volume>12</volume>
            <issue>7</issue>
            <fpage>1162</fpage>
            <page-range>1162-1172</page-range>
            <pub-id pub-id-type="pmid">28515156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jelakovi&#x00107;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dika</surname>
                <given-names>&#x0017d;</given-names>
              </name>
              <name>
                <surname>Arlt</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Stiborova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pavlovi&#x00107;</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Nikoli&#x00107;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Colet</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Vanherweghem</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Nortier</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.</article-title>
            <source>Semin Nephrol</source>
            <year>2019</year>
            <month>May</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>284</fpage>
            <page-range>284-296</page-range>
            <pub-id pub-id-type="pmid">31054628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goicoechea</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-G&#x000f3;mez</surname>
                <given-names>JM</given-names>
              </name>
              <collab>Spanish Registry of Glomerulonephritis</collab>
            </person-group>
            <article-title>Increased prevalence of acute tubulointerstitial nephritis.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>112</fpage>
            <page-range>112-5</page-range>
            <pub-id pub-id-type="pmid">22759386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Broe</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Elseviers</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Over-the-counter analgesic use.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>10</issue>
            <fpage>2098</fpage>
            <page-range>2098-103</page-range>
            <pub-id pub-id-type="pmid">19423685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Praga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Acute interstitial nephritis.</article-title>
            <source>Kidney Int</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>77</volume>
            <issue>11</issue>
            <fpage>956</fpage>
            <page-range>956-61</page-range>
            <pub-id pub-id-type="pmid">20336051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hosohata</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Role of Oxidative Stress in Drug-Induced Kidney Injury.</article-title>
            <source>Int J Mol Sci</source>
            <year>2016</year>
            <month>Nov</month>
            <day>01</day>
            <volume>17</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">27809280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r35">
          <label>35</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Finnigan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Rout</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Bashir</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Allergic and Drug-Induced Interstitial Nephritis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>9</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">29493948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joyce</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Glasner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ranganathan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Swiatecka-Urban</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Tubulointerstitial nephritis: diagnosis, treatment, and monitoring.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>577</fpage>
            <page-range>577-587</page-range>
            <pub-id pub-id-type="pmid">27155873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caravaca-Font&#x000e1;n</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Ju&#x000e1;rez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Praga</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acute kidney injury in interstitial nephritis.</article-title>
            <source>Curr Opin Crit Care</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>558</fpage>
            <page-range>558-564</page-range>
            <pub-id pub-id-type="pmid">31503026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rangan</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tay</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Coombes</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Effect of nephrotoxins on tubulointerstitial injury and NF-kappaB activation in Adriamycin nephropathy.</article-title>
            <source>Ren Fail</source>
            <year>2005</year>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>609</fpage>
            <page-range>609-14</page-range>
            <pub-id pub-id-type="pmid">16153002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Renal fibrosis: new insights into the pathogenesis and therapeutics.</article-title>
            <source>Kidney Int</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>69</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-7</page-range>
            <pub-id pub-id-type="pmid">16408108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krishnan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment.</article-title>
            <source>Iran J Kidney Dis</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-13</page-range>
            <pub-id pub-id-type="pmid">25599729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruebner</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Fadrowski</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Tubulointerstitial Nephritis.</article-title>
            <source>Pediatr Clin North Am</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-119</page-range>
            <pub-id pub-id-type="pmid">30454737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Markowitz</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced acute interstitial nephritis.</article-title>
            <source>Nat Rev Nephrol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>6</volume>
            <issue>8</issue>
            <fpage>461</fpage>
            <page-range>461-70</page-range>
            <pub-id pub-id-type="pmid">20517290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Clinical Approach to Diagnosing Acute and Chronic Tubulointerstitial Disease.</article-title>
            <source>Adv Chronic Kidney Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>57</fpage>
            <page-range>57-63</page-range>
            <pub-id pub-id-type="pmid">28284380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fogo</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Lusco</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Najafian</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alpers</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>AJKD Atlas of Renal Pathology: Acute Interstitial Nephritis.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>67</volume>
            <issue>6</issue>
            <fpage>e35</fpage>
            <page-range>e35-6</page-range>
            <pub-id pub-id-type="pmid">27211376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez-Iturbe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Role of inflammatory cells in the kidney in the induction and maintenance of hypertension.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>260</fpage>
            <page-range>260-3</page-range>
            <pub-id pub-id-type="pmid">16326746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaziri</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension.</article-title>
            <source>Curr Opin Nephrol Hypertens</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-9</page-range>
            <pub-id pub-id-type="pmid">15090865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez-Iturbe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Quiroz</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ferrebuz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parra</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vaziri</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats.</article-title>
            <source>Am J Nephrol</source>
            <year>2004</year>
            <season>Nov-Dec</season>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>587</fpage>
            <page-range>587-94</page-range>
            <pub-id pub-id-type="pmid">15564764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moledina</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Differentiating Acute Interstitial Nephritis from Acute Tubular Injury: A Challenge for Clinicians.</article-title>
            <source>Nephron</source>
            <year>2019</year>
            <volume>143</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-216</page-range>
            <pub-id pub-id-type="pmid">31203275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spargo</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Wit</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Meehan</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>433</fpage>
            <page-range>433-47</page-range>
            <pub-id pub-id-type="pmid">10692269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kodner</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kudrimoti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of acute interstitial nephritis.</article-title>
            <source>Am Fam Physician</source>
            <year>2003</year>
            <month>Jun</month>
            <day>15</day>
            <volume>67</volume>
            <issue>12</issue>
            <fpage>2527</fpage>
            <page-range>2527-34</page-range>
            <pub-id pub-id-type="pmid">12825841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moledina</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Drug-Induced Acute Interstitial Nephritis.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2017</year>
            <month>Dec</month>
            <day>07</day>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>2046</fpage>
            <page-range>2046-2049</page-range>
            <pub-id pub-id-type="pmid">28893923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvador</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Carolina</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Jes&#x000fa;s</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Virgilia</surname>
                <given-names>SAM</given-names>
              </name>
              <name>
                <surname>Susana</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Jonathan</surname>
                <given-names>C&#x000cd;</given-names>
              </name>
              <name>
                <surname>Luis</surname>
                <given-names>SPJ</given-names>
              </name>
              <name>
                <surname>Claudio</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A low BUN/creatinine ratio predicts histologically confirmed acute interstitial nephritis.</article-title>
            <source>BMC Nephrol</source>
            <year>2023</year>
            <month>Mar</month>
            <day>27</day>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <pub-id pub-id-type="pmid">36967386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Border</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Holbrook</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Gallium citrate Ga 67 scanning in acute renal failure.</article-title>
            <source>West J Med</source>
            <year>1995</year>
            <month>May</month>
            <volume>162</volume>
            <issue>5</issue>
            <fpage>477</fpage>
            <page-range>477-8</page-range>
            <pub-id pub-id-type="pmid">7785274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Linton</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Richmond</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Lindsay</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Driedger</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Lamki</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Gallium67 scintigraphy in the diagnosis of acute renal disease.</article-title>
            <source>Clin Nephrol</source>
            <year>1985</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>84</fpage>
            <page-range>84-7</page-range>
            <pub-id pub-id-type="pmid">3862487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hettinga</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Scheerlinck</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Lilien</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Rothova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Boer</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>The value of measuring urinary &#x003b2;2-microglobulin and serum creatinine for detecting tubulointerstitial nephritis and uveitis syndrome in young patients with uveitis.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>133</volume>
            <issue>2</issue>
            <fpage>140</fpage>
            <page-range>140-5</page-range>
            <pub-id pub-id-type="pmid">25356569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moledina</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Obeid</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Rosales</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sise</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Moeckel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kashgarian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuperman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Lefferts</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meliambro</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bitzer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Luciano</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Pober</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Cantley</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Colvin</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis.</article-title>
            <source>J Clin Invest</source>
            <year>2023</year>
            <month>Jul</month>
            <day>03</day>
            <volume>133</volume>
            <issue>13</issue>
            <pub-id pub-id-type="pmid">37395276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Canney</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Hiremath</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Biomarkers in acute kidney injury: On the cusp of a new era?</article-title>
            <source>J Clin Invest</source>
            <year>2023</year>
            <month>Jul</month>
            <day>03</day>
            <volume>133</volume>
            <issue>13</issue>
            <pub-id pub-id-type="pmid">37395275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fogazzi</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Garigali</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Simonini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Consonni</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Urinary sediment findings in acute interstitial nephritis.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>60</volume>
            <issue>2</issue>
            <fpage>330</fpage>
            <page-range>330-2</page-range>
            <pub-id pub-id-type="pmid">22677261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guti&#x000e9;rrez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Galeano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chevia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>de Sequera</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bernis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parra</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Delgado</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sanz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ortiz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goicoechea</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quereda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Olea</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bouarich</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Segovia</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Praga</surname>
                <given-names>M</given-names>
              </name>
              <collab>Grupo Madrile&#x000f1;o De Nefritis Intersticiales</collab>
            </person-group>
            <article-title>Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis.</article-title>
            <source>Kidney Int</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>73</volume>
            <issue>8</issue>
            <fpage>940</fpage>
            <page-range>940-6</page-range>
            <pub-id pub-id-type="pmid">18185501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinto</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Sukkar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gallagher</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of corticosteroid compared with non-corticosteroid therapy for the treatment of drug-induced acute interstitial nephritis: a systematic review.</article-title>
            <source>Intern Med J</source>
            <year>2019</year>
            <month>May</month>
            <volume>49</volume>
            <issue>5</issue>
            <fpage>562</fpage>
            <page-range>562-569</page-range>
            <pub-id pub-id-type="pmid">30129289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carter-Monroe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Atta</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Granulomatous interstitial nephritis.</article-title>
            <source>Clin Kidney J</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>516</fpage>
            <page-range>516-23</page-range>
            <pub-id pub-id-type="pmid">26413275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chowdry</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Azad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mir</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Najar</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Ashraf</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Muzafar</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>WI</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced acute interstitial nephritis: Prospective randomized trial comparing oral steroids and high-dose intravenous pulse steroid therapy in guiding the treatment of this condition.</article-title>
            <source>Saudi J Kidney Dis Transpl</source>
            <year>2018</year>
            <season>May-Jun</season>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>598</fpage>
            <page-range>598-607</page-range>
            <pub-id pub-id-type="pmid">29970736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramachandran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nada</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jha</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Kohli</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced acute interstitial nephritis: A clinicopathological study and comparative trial of steroid regimens.</article-title>
            <source>Indian J Nephrol</source>
            <year>2015</year>
            <season>Sep-Oct</season>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>281</fpage>
            <page-range>281-6</page-range>
            <pub-id pub-id-type="pmid">26628793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joss</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Geddes</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Granulomatous interstitial nephritis.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>222</fpage>
            <page-range>222-30</page-range>
            <pub-id pub-id-type="pmid">17699417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Valderrama</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mattana</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Esposito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Singhal</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Vancomycin-induced acute granulomatous interstitial nephritis: therapeutic options.</article-title>
            <source>Am J Med Sci</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>334</volume>
            <issue>4</issue>
            <fpage>296</fpage>
            <page-range>296-300</page-range>
            <pub-id pub-id-type="pmid">18030187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takemura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miyazato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maruyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yoshioka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Course and outcome of tubulointerstitial nephritis and uveitis syndrome.</article-title>
            <source>Am J Kidney Dis</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>1016</fpage>
            <page-range>1016-21</page-range>
            <pub-id pub-id-type="pmid">10585310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Preddie</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Markowitz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nickolas</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>D'Agati</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>Schwimmer</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Gardenswartz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Appel</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Mycophenolate mofetil for the treatment of interstitial nephritis.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>718</fpage>
            <page-range>718-22</page-range>
            <pub-id pub-id-type="pmid">17699278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhat</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tonutti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Timilsina</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Selmi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gershwin</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity.</article-title>
            <source>Clin Rev Allergy Immunol</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-100</page-range>
            <pub-id pub-id-type="pmid">37338709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neilson</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Farris</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Case records of the Massachusetts General Hospital. Case 21-2009. A 61-year-old woman with abdominal pain, weight loss, and renal failure.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Jul</month>
            <day>09</day>
            <volume>361</volume>
            <issue>2</issue>
            <fpage>179</fpage>
            <page-range>179-87</page-range>
            <pub-id pub-id-type="pmid">19587344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gafter</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kalechman</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zevin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Korzets</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Livni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sredni</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Tubulointerstitial nephritis and uveitis: association with suppressed cellular immunity.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>1993</year>
            <volume>8</volume>
            <issue>9</issue>
            <fpage>821</fpage>
            <page-range>821-6</page-range>
            <pub-id pub-id-type="pmid">8255514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kenouch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Belghiti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Di Costanzo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>M&#x000e9;ry</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>[A new syndrome: acute interstitial nephropathy with uveitis. Apropos of a case].</article-title>
            <source>Ann Med Interne (Paris)</source>
            <year>1989</year>
            <volume>140</volume>
            <issue>3</issue>
            <fpage>169</fpage>
            <page-range>169-72</page-range>
            <pub-id pub-id-type="pmid">2669595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dahlberg</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Frecentese</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Cogbill</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Cholesterol embolism: experience with 22 histologically proven cases.</article-title>
            <source>Surgery</source>
            <year>1989</year>
            <month>Jun</month>
            <volume>105</volume>
            <issue>6</issue>
            <fpage>737</fpage>
            <page-range>737-46</page-range>
            <pub-id pub-id-type="pmid">2727901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chadban</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Atkins</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Glomerulonephritis.</article-title>
            <source>Lancet</source>
            <year>2005</year>
            <month>May</month>
            <day>21-27</day>
            <volume>365</volume>
            <issue>9473</issue>
            <fpage>1797</fpage>
            <page-range>1797-806</page-range>
            <pub-id pub-id-type="pmid">15910953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r74">
          <label>74</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kazi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hashmi</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <chapter-title>Glomerulonephritis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">32809479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r75">
          <label>75</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Rishor-Olney</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Hinson</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <chapter-title>Obstructive Uropathy</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>22</day>
            <pub-id pub-id-type="pmid">32644347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iyasere</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Urinary tract obstruction.</article-title>
            <source>Br J Hosp Med (Lond)</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>73</volume>
            <issue>12</issue>
            <fpage>696</fpage>
            <page-range>696-700</page-range>
            <pub-id pub-id-type="pmid">23502199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Neilson</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>Toward a unified theory of renal progression.</article-title>
            <source>Annu Rev Med</source>
            <year>2006</year>
            <volume>57</volume>
            <fpage>365</fpage>
            <page-range>365-80</page-range>
            <pub-id pub-id-type="pmid">16409155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>V&#x000f4;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yombi</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Demoulin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yildiz</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>TINU-associated Fanconi syndrome: a case report and review of literature.</article-title>
            <source>BMC Nephrol</source>
            <year>2018</year>
            <month>Oct</month>
            <day>19</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>274</fpage>
            <pub-id pub-id-type="pmid">30340545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wen</surname>
                <given-names>YK</given-names>
              </name>
            </person-group>
            <article-title>Tubulointerstitial nephritis and uveitis with Fanconi syndrome in a patient with ankylosing spondylitis.</article-title>
            <source>Clin Nephrol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>72</volume>
            <issue>4</issue>
            <fpage>315</fpage>
            <page-range>315-8</page-range>
            <pub-id pub-id-type="pmid">19825339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koike</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Usui</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fukami</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ueda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tamaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okuda</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Adult-onset acute tubulointerstitial nephritis and uveitis with Fanconi syndrome. Case report and review of the literature.</article-title>
            <source>Clin Nephrol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>255</fpage>
            <page-range>255-9</page-range>
            <pub-id pub-id-type="pmid">17474563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wen</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Transformation from tubulointerstitial nephritis to crescentic glomerulonephritis: an unusual presentation of ANCA-associated renal vasculitis.</article-title>
            <source>Ren Fail</source>
            <year>2006</year>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-91</page-range>
            <pub-id pub-id-type="pmid">16538980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25698.r82">
          <label>82</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Parmar</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Bashir</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Crescentic Glomerulonephritis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>2</month>
            <day>20</day>
            <pub-id pub-id-type="pmid">28613478</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
